Skip to content
healthcare.dev

LIRAGLUTIDE

NDC 69097-920, LIRAGLUTIDE, injection, solution, from Cipla USA Inc..

Product NDC
69097-920
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217590
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-920 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LIRAGLUTIDE6 mg/mL

Pharmacologic classes

GLP-1 Receptor Agonist [EPC]; Glucagon-Like Peptide 1 [CS]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]

Package NDCNDC-11Package
69097-920-67690970920672 SYRINGE, PLASTIC in 1 CARTON (69097-920-67) / 3 mL in 1 SYRINGE, PLASTIC
69097-920-68690970920683 SYRINGE, PLASTIC in 1 CARTON (69097-920-68) / 3 mL in 1 SYRINGE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8fe557ae-4ff0-47a2-8ec3-37bb0fbdcc64
  • NADAC price for package 69097092067

    GET /v1/drugs/nadac/69097092067
  • NADAC price for package 69097092068

    GET /v1/drugs/nadac/69097092068

Use it

Look up 69097-920 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-920 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-920. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.